Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Portfolio Pulse from
Prenetics, a Nasdaq-listed health sciences company, has officially launched IM8 Health in partnership with David Beckham. This marks Prenetics' entry into the $187 billion global consumer health market. The launch follows Prenetics' acquisition of Europa, a major sports nutrition distributor in the U.S.
November 18, 2024 | 11:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Prenetics has launched IM8 Health in partnership with David Beckham, marking its entry into the global consumer health market. This follows its acquisition of Europa, a major sports nutrition distributor.
The launch of IM8 Health with a high-profile partner like David Beckham and the recent acquisition of Europa positions Prenetics for growth in the large consumer health market, likely boosting investor confidence and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100